vs
Side-by-side financial comparison of Ellington Financial Inc. (EFC) and VIEMED HEALTHCARE, INC. (VMD). Click either name above to swap in a different company.
Ellington Financial Inc. is the larger business by last-quarter revenue ($78.2M vs $76.2M, roughly 1.0× VIEMED HEALTHCARE, INC.). Ellington Financial Inc. runs the higher net margin — 28.9% vs 7.4%, a 21.5% gap on every dollar of revenue. On growth, VIEMED HEALTHCARE, INC. posted the faster year-over-year revenue change (25.5% vs 8.7%). Over the past eight quarters, VIEMED HEALTHCARE, INC.'s revenue compounded faster (22.7% CAGR vs 1.8%).
Ellington Management Group is an American hedge fund firm. As of June 2019, the firm was reportedly managing $8.5 billion in structured products and other credit instruments.
Viemed Healthcare, Inc. is a medical technology firm specializing in respiratory care solutions. It develops, manufactures and distributes portable ventilators, respiratory therapy devices and related support services, catering to acute care, post-acute care and home care segments across North America, Europe and key Asia-Pacific markets for patients with respiratory conditions.
EFC vs VMD — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $78.2M | $76.2M |
| Net Profit | $22.6M | $5.6M |
| Gross Margin | — | 57.9% |
| Operating Margin | 7.4% | 11.0% |
| Net Margin | 28.9% | 7.4% |
| Revenue YoY | 8.7% | 25.5% |
| Net Profit YoY | -26.2% | 30.7% |
| EPS (diluted) | $0.10 | $0.14 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $78.2M | $76.2M | ||
| Q3 25 | $82.8M | $71.9M | ||
| Q2 25 | $92.5M | $63.1M | ||
| Q1 25 | $82.9M | $59.1M | ||
| Q4 24 | $72.0M | $60.7M | ||
| Q3 24 | $67.0M | $58.0M | ||
| Q2 24 | $91.2M | $55.0M | ||
| Q1 24 | $75.5M | $50.6M |
| Q4 25 | $22.6M | $5.6M | ||
| Q3 25 | $29.5M | $3.5M | ||
| Q2 25 | $42.9M | $3.2M | ||
| Q1 25 | $31.6M | $2.6M | ||
| Q4 24 | $30.7M | $4.3M | ||
| Q3 24 | $16.2M | $3.9M | ||
| Q2 24 | $52.3M | $1.5M | ||
| Q1 24 | $26.9M | $1.6M |
| Q4 25 | — | 57.9% | ||
| Q3 25 | — | 57.5% | ||
| Q2 25 | — | 58.3% | ||
| Q1 25 | — | 56.3% | ||
| Q4 24 | — | 59.5% | ||
| Q3 24 | — | 59.3% | ||
| Q2 24 | — | 59.8% | ||
| Q1 24 | — | 58.9% |
| Q4 25 | 7.4% | 11.0% | ||
| Q3 25 | 31.1% | 7.8% | ||
| Q2 25 | 38.3% | 8.1% | ||
| Q1 25 | 37.3% | 6.5% | ||
| Q4 24 | 28.0% | 10.6% | ||
| Q3 24 | 24.0% | 9.7% | ||
| Q2 24 | 52.8% | 6.6% | ||
| Q1 24 | 42.2% | 4.4% |
| Q4 25 | 28.9% | 7.4% | ||
| Q3 25 | 35.7% | 4.9% | ||
| Q2 25 | 46.4% | 5.0% | ||
| Q1 25 | 38.2% | 4.4% | ||
| Q4 24 | 42.6% | 7.1% | ||
| Q3 24 | 24.1% | 6.7% | ||
| Q2 24 | 57.4% | 2.7% | ||
| Q1 24 | 35.6% | 3.2% |
| Q4 25 | $0.10 | $0.14 | ||
| Q3 25 | $0.29 | $0.09 | ||
| Q2 25 | $0.45 | $0.08 | ||
| Q1 25 | $0.35 | $0.06 | ||
| Q4 24 | $0.23 | $0.10 | ||
| Q3 24 | $0.19 | $0.10 | ||
| Q2 24 | $0.62 | $0.04 | ||
| Q1 24 | $0.32 | $0.04 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $201.9M | $13.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.8B | $141.5M |
| Total Assets | $19.4B | $199.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $201.9M | $13.5M | ||
| Q3 25 | $184.8M | $11.1M | ||
| Q2 25 | $211.0M | $20.0M | ||
| Q1 25 | $203.3M | $10.2M | ||
| Q4 24 | $192.4M | $17.5M | ||
| Q3 24 | $217.7M | $11.3M | ||
| Q2 24 | $198.5M | $8.8M | ||
| Q1 24 | $187.5M | $7.3M |
| Q4 25 | $1.8B | $141.5M | ||
| Q3 25 | $1.8B | $133.6M | ||
| Q2 25 | $1.7B | $139.7M | ||
| Q1 25 | $1.6B | $134.8M | ||
| Q4 24 | $1.6B | $131.4M | ||
| Q3 24 | $1.6B | $125.0M | ||
| Q2 24 | $1.6B | $119.4M | ||
| Q1 24 | $1.5B | $116.3M |
| Q4 25 | $19.4B | $199.2M | ||
| Q3 25 | $17.8B | $202.4M | ||
| Q2 25 | $17.1B | $184.6M | ||
| Q1 25 | $16.6B | $178.1M | ||
| Q4 24 | $16.3B | $177.1M | ||
| Q3 24 | $16.0B | $169.5M | ||
| Q2 24 | $15.1B | $163.9M | ||
| Q1 24 | $15.1B | $154.9M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-925.5M | $18.4M |
| Free Cash FlowOCF − Capex | — | $9.7M |
| FCF MarginFCF / Revenue | — | 12.7% |
| Capex IntensityCapex / Revenue | 0.0% | 11.5% |
| Cash ConversionOCF / Net Profit | -40.92× | 3.27× |
| TTM Free Cash FlowTrailing 4 quarters | — | $11.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-925.5M | $18.4M | ||
| Q3 25 | $-290.4M | $18.4M | ||
| Q2 25 | $-210.5M | $12.3M | ||
| Q1 25 | $-126.4M | $2.9M | ||
| Q4 24 | $-430.5M | $15.0M | ||
| Q3 24 | $-141.7M | $12.7M | ||
| Q2 24 | $-88.6M | $10.2M | ||
| Q1 24 | $-59.5M | $1.2M |
| Q4 25 | — | $9.7M | ||
| Q3 25 | — | $10.7M | ||
| Q2 25 | — | $4.1M | ||
| Q1 25 | — | $-12.6M | ||
| Q4 24 | — | $3.2M | ||
| Q3 24 | — | $1.7M | ||
| Q2 24 | — | $1.2M | ||
| Q1 24 | — | $-4.8M |
| Q4 25 | — | 12.7% | ||
| Q3 25 | — | 14.9% | ||
| Q2 25 | — | 6.5% | ||
| Q1 25 | — | -21.4% | ||
| Q4 24 | — | 5.2% | ||
| Q3 24 | — | 3.0% | ||
| Q2 24 | — | 2.3% | ||
| Q1 24 | — | -9.5% |
| Q4 25 | 0.0% | 11.5% | ||
| Q3 25 | — | 10.6% | ||
| Q2 25 | — | 12.9% | ||
| Q1 25 | — | 26.2% | ||
| Q4 24 | 0.0% | 19.5% | ||
| Q3 24 | 0.0% | 19.0% | ||
| Q2 24 | 0.0% | 16.3% | ||
| Q1 24 | 0.0% | 11.9% |
| Q4 25 | -40.92× | 3.27× | ||
| Q3 25 | -9.84× | 5.23× | ||
| Q2 25 | -4.90× | 3.88× | ||
| Q1 25 | -3.99× | 1.09× | ||
| Q4 24 | -14.04× | 3.47× | ||
| Q3 24 | -8.76× | 3.29× | ||
| Q2 24 | -1.69× | 6.94× | ||
| Q1 24 | -2.21× | 0.73× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
